Fritextsökning
Innehållstyper
-
Neurovive inleder fas II-studie
Första patienten rekryterad till studien Ciprics, på akut njurskada vid hjärtkirurgi.
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
Biogaia's advance goes on
In December Biogaia reached China and North America. Now, the Swedish probiotic company has entered the Mexican market.
-
Rapid and thorough homogenization of samples
MP Biomedicals presents the Fasprep-24 instrument, a new high-throughput model of the earlier Bio 101 Systems Fastprep homogenizer.
-
Age essential when testing drugs
Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...
-
Ten recieve the Venture Cup West Prize
At this year´s Venture Cup West awards the 10 best business ideas in Venture Cup West 08/09 were chosen, receiving SEK 10 000 each.
-
KI Innovations säljer projekt
Smartwise köper medtechprojektet Extroducer.
-
Collaboration brings next generation drugs
Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.
-
Vattenfall is firing with biomass
Vattenfall will provide Denmark with electricity by means of biomass.
-
Zenicor får stororder
Företaget får sin största order hittills när instrumentet Zenicor EKG används i projekt för strokeprevention.
-
Printing sensors for biological samples
Acreo develops technologies for printed electronics. Using organic printers, Acreo can print a transistor where biological samples can be placed.
-
Waukesha Universalpumpar på lager! | AxFlow AB
Waukesha pumparna är helt i rostfritt stål som standard och finns i lager från AxFlow europeiska distributionscenter i Lelystad (NL). Många storlekar finns i la...
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Materielbristen förväntas bli värre under veckan
Bristen på skyddsutrustning spås bli allt allvarligare de kommande dagarna i Sverige. Materielbristen är ett problem i flera länder och nu varnar New Yorks borg...
-
HPV-vaccin gav kraftig nedgång av livmoderhalscancer
HPV-vaccinet, som ges till skolbarn, minskade förekomsten av livmoderhalscancer med hela 87 procent i en brittisk studie.
-
Re-painting the big pig-ture
Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.
-
Framgång för Moberg mot svamp-konkurrent
Bolaget får bifall från NAD i sin anmälan av huvudkonkurrentens vilseledande marknadsföring.
-
Platelet analysis in whole blood
The new Multiplate analyzer from Triolab uses impedance aggregometry to measure the effects of platelet inhibitors on whole blood.
-
First ever study of human stem cell treatment
The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.
-
Danish biorefinery can save US billions
The Danish Inbicon biorefinery process could save the US billions on foreign oil, the organization states.
-
Measure blood sugar without finger pricking
The Danish entrepreneurial firm RSP Systems has developed a method to measure the blood sugar level in diabetes patients, simply by placing a fingertip on a sma...
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
-
Sofia Nilsson (C): ”Life science-strategin behöver tydligare prioriteringar”
Centerpartiet vill inrätta ett tioårigt forskningsprogram om sjukdomar som drabbar kvinnor. Det berättar Sofia Nilsson (C), i Life Science Swedens intervjuserie...
-
Johnson & Johnson pausar vaccinprövningar
Sedan en patient drabbats av en oförklarlig sjukdom pausar läkemedelsföretaget tillfälligt alla läkemedelsprövningar med sitt vaccin mot covid-19.
BREAKING